Breast cancer translational career program to build leaders
Official title: Career Enhancement Program
Funded at Sloan-Kettering Inst Can Research · NIH-11422222 · Data updated 2026-11-12
A grant funds a program to train physicians and scientists to lead translational breast cancer research and improve patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 13, 2020 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $88,750 |
| NIH project number | 2P50CA247749-06A1 |
| Project ID | NIH-11422222 on NIH RePORTER |
Who could benefit from this research
✓Could help
Physicians and scientists who aim to pursue independent translational research careers in breast cancer.
✕Less likely to help
Patients may not directly participate in the program, but may benefit indirectly from the researchers it trains.
What this research studies
This program supports developing leaders in breast cancer translational research at MSKCC, focusing on mentoring, clinical investigation skills, and integration of basic science with patient care. It uses existing training infrastructure to help physicians and scientists pursue independent careers in the field. The goal is to connect discoveries about DNA repair defects and genetic instability with targeted treatments for individual patients. Participants will benefit from mentoring, cross-disciplinary collaboration, and access to translational platforms.
Why it matters
Potential benefit: The program aims to create future researchers who will accelerate new, patient-centered breast cancer therapies.
How similar studies have gone: Prior SPORE CEP activities have produced leadership in translational breast cancer research, with ongoing programs and mentoring networks.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Powell, Simon N. — Sloan-Kettering Inst Can Research
- Study coordinator: Powell, Simon N.
Related research
Other NIH-funded projects on the same topics.
-
Understand how skeletal muscle nuclei specialize and arrange themselves for proper muscle function
A study to uncover how the hundreds of nuclei in skeletal muscle fibers acquire different roles and positions to keep muscles strong and healthy.
-
Genomic profiling and outcomes of cancers in World Trade Center-exposed survivors and responders
This project looks at the genetic makeup and real-world cancer outcomes in people exposed to the World Trade Center disaster to understand how their cancers behave and respond to treatments.
-
Meaning-Centered Psychotherapy for Mexican Patients with Advanced Cancer
A cancer center in Mexico will test a culturally adapted therapy to help Mexican patients with advanced cancer find meaning, peace, and purpose at the end of life.
-
High-specificity genome-scale cell-surface proteomics to find tumor targets
A cancer research project is trying to map all the proteins on the surface of ultra-rare sarcoma cells to find safe, targeted ways to treat them.
-
Priorities for testing and choosing combination therapies in rhabdoid tumors to guide clinical trials
A coordinated, multi-site effort will rigorously test promising drug combinations in rhabdoid tumors to identify the most promising options for future patient trials.
-
ecDNA in Cancer: Understanding and targeting circular DNA that drives tumor growth
A cancer-focused project to understand how extrachromosomal DNA helps tumors grow and resist treatment, and to develop new ways to target these mechanisms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.